Security record · archived quarter
TFX
Teleflex Incorporated · Healthcare · Medical - Instruments & Supplies
1Tracked holders
-1Δ holders
7.58KShares held
$940,846Reported value
+0New positions
−1Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2026
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | -1 | 7.58K | $940,846 | n/a | −1 |
| Q2 2026 | 114 | +2 | 26.38M | $3.34B | +8 | −5 |
| Q1 2026 | 114 | +1 | 27.79M | $3.32B | +11 | −11 |
| Q4 2025 | 113 | -1 | 32.06M | $3.91B | +1 | −1 |
| Q3 2025 | 18 | -1 | 20.02M | $2.45B | n/a | −2 |
| Q2 2025 | 17 | +1 | 15.00M | $1.78B | +1 | n/a |
| Q1 2025 | 13 | -2 | 4.93M | $680.71M | +1 | −3 |
| Q4 2024 | 15 | -1 | 5.33M | $947.44M | +1 | −2 |
| Q3 2024 | 15 | -1 | 3.86M | $954.17M | +1 | −2 |
| Q2 2024 | 16 | n/a | 4.92M | $1.03B | n/a | n/a |
Who holds it · Q3 2026
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wealth Enhancement Advisory… | 7.58K | -25.1% | $940,846 | 0.0% | ▼ Trim | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Assenagon Asset Management… | $2.78M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 364 holders, 47.78M shares, $5.00B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Sep 08
SC 13G/A: Janus Henderson Group Ltd.
Aug 14
SC 13G/A: T. Rowe Price Investment Management…
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q3 2026 ·
Methodology ·
Get this via the API